Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nanobiotix S.A. - ADSs (NQ:NBTX)

7.380 +0.190 (+2.64%)
Streaming Delayed Price Updated: 3:59 PM EDT, Aug 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nanobiotix S.A. - ADSs

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
NANOBIOTIX to Announce Third Quarter 2022 Financial Results on November 9, 2022
Conference Call and Webcast to be Held at 8:00 AM ET / 2:00 PM CET on November 10, 2022 
From Nanobiotix S.A.
Via GlobeNewswire
NANOBIOTIX Executes Definitive Agreement to Restructure Existing Loan With the European Investment Bank
From Nanobiotix S.A.
Via GlobeNewswire
Nanobiotix: Voting Rights and Shares Capital of the Company
From Nanobiotix
Via Business Wire
Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022
From Nanobiotix
Via Business Wire
Earnings Scheduled For September 28, 2022
Companies Reporting Before The Bell • Lilium (NASDAQ:LILM) is expected to report earnings for its second quarter. 
Via Benzinga
Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022
From Nanobiotix
Via Business Wire
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell... 
Via Benzinga
Nanobiotix Establishes Recommended Dose for Planned Registrational Study Evaluating NBTXR3 Plus Anti-PD-1 for Patients With Metastatic Head and Neck Cancer Resistant to Prior Immunotherapy
From Nanobiotix
Via Business Wire
Nanobiotix Announces Agreement in Principle to Restructure Existing Loan Agreement With European Investment Bank, Extending Operating Runway Into Q1 2024
From Nanobiotix
Via Business Wire
Nanobiotix: Voting Rights and Shares Capital of the Company
From Nanobiotix
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! It's time for another overview of the biggest pre-market stock movers as we see what's happening on Thursday! 
Via InvestorPlace
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
 
Via Benzinga
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer
From NANOBIOTIX
Via Business Wire
NANOBIOTIX Co-Founder and CEO Laurent Levy Named to 2022 PharmaVoice 100 List of Most Inspiring People in Life Sciences
From NANOBIOTIX
Via Business Wire
Nanobiotix to Present During the H.C. Wainwright Global Investment Conference in September 2022
From NANOBIOTIX
Via Business Wire
NANOBIOTIX: Voting Rights and Shares Capital of the Company
From Nanobiotix
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
  
Via Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday. 
Via Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million. 
Via Benzinga
Half-year Report on the Nanobiotix Liquidity Contract With Gilbert Dupont
From Nanobiotix
Via Business Wire
NANOBIOTIX: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
From Nanobiotix
Via Business Wire
NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications
From NANOBIOTIX
Via Business Wire
NANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022
From Nanobiotix
Via Business Wire
CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update
From Nanobiotix
Via Business Wire
NANOBIOTIX Provides First Quarter Operational and Financial Update
From Nanobiotix
Via Business Wire
NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022
From Nanobiotix
Via Business Wire
NANOBIOTIX to Participate in Two Upcoming Investor Conferences
From Nanobiotix
Via Business Wire
7 Biotech Stocks With Key Catalysts for May
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.